SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001019687-06-000599
Filing Date
2006-03-17
Accepted
2006-03-17 10:35:16
Documents
4
Period of Report
2006-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PEREGRINE PHARMACEUTICALS, INC. peregrine_8k-031706.htm 8-K 59715
2 CERTIFICATE OF DESIGNATION peregrine_ex0307.htm EX-3.7 44705
3 RIGHTS AGREEMENT peregrine_ex0419.htm EX-4.19 449716
4 PRESS RELEASE peregrine_8k-ex9901.htm EX-99.1 16428
  Complete submission text file 0001019687-06-000599.txt   572477
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 000-17085 | Film No.: 06694358
SIC: 2835 In Vitro & In Vivo Diagnostic Substances